• Telephone : (855) 802-0299
  • Email Address: IR@GreenHygienics.com
  • Head Office: | POWAY, CA | 92064

Category Archives: News








  • The company plans to incorporate systemic environmental, social, and governance (“ESG”) factors into business planning and investment decision-making

  • The initial Sustainability Accounting Standards Board (“SASB”) report has been completed, and sustainability consulting firm KERMIDA Inc. is currently organizing the data compiled by Green Hygienics

  • An ESG program can significantly benefit companies in the industry, from drawing in more investors to winning new business, gaining better talent and improving media coverage

  • The industrial hemp market size is expected to reach $15.26 billion by 2027 due to the rising demand for food, supplements, cosmetics, and personal care items


Green Hygienics Holdings (OTCQB: GRYN), a California-based innovative and tech-based enterprise that is focused on the high cultivation standards, processing, and manufacturing of industrial hemp for pharmaceutical-grade bioactive cannabinoids, is enhancing its corporate responsibility and sustainability goals to empower environmental progress. The company plans to incorporate systemic environmental, social, and governance (“ESG”) factors into business planning and investment decision-making.

With the help of KERAMIDA Inc., a premier sustainability consulting firm, Green Hygienics is developing a Sustainability and ESG report using the Sustainability Accounting Standards Board (“SASB”) framework, maintained by the Value Reporting Foundation. Sustainability and ESG are an integral part of the Company’s value system and are committed to driving sustainability by becoming a more effective corporate citizen.

Green Hygienics is the first industrial hemp company to undertake a Sustainability and ESG report. The company is getting ahead of the government’s push to require ESG metrics measurement and reporting. Investors are also pressuring companies to measure, benchmark, and report ESG metrics. These investors pay a premium on companies that develop strong ESG policies. These are the companies that are seeing better valuations and market performance.

According to a Hemp Industry Daily report, companies of all sizes in the industry can realize significant benefits from developing a corporate responsibility program, including (https://cnw.fm/T1z8I):

Winning new business and increasing customer retention

  • Attracting talent and maintaining an exuberant workforce

  • Positive media

  • Differentiation from competitors

  • Saving money on energy and operating costs


ESG goals are achievable by any firm by breaking down the concept into different components:

  • Environmental impact – covering everything from a company’s greenhouse gas emissions to resource depletion, nature conservation, waste, and pollution.

  • Social impact – including a firm’s working conditions, employee relations, health, and safety. It also includes a firm’s interaction with local and indigenous communities.

  • Governance – consisting of the structures within a company, like the board of directors, diversity, pay equity, political lobbying, tax strategy, supply chain policies, and executive pay.


ESG is the measurement of all these different aspects, benchmarking them, and reporting them.

Green Hygienics is positioned to deliver a secure supply chain solution and product efficacy to a range of industry customers and leverage the strategic advantages within its own consumer brand portfolio, securing a strong position in the expanding hemp market. The size of the industrial hemp sector is expected to reach $15.26 billion by 2027, expanding at a CAGR of 15.8% over the forecast period. In North America, the market is expected to expand by a CAGR of 20.4% from 2020 to 2027 due to the rising demand for food, supplements, cosmetics, and personal care items (https://cnw.fm/j1xXX).

Developing an ESG program is likely to further cement Green Hygienics’ position in the market, as well as influence positive investor interest and growth opportunities. The company has already finished its SASB Report process and is now interviewing and collecting data from utilities, while also organizing the related data for the KERMIDA Inc. team. Green Hygienics hopes to create the final ESG report in about a month.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

https://www.hempwire.com/green-hygienics-holdings-inc-gryn-to-become-first-hemp-company-to-develop-esg-report-using-sasb-framework/



  • Green Hygienics has launched TruLife Biotech LLC. to focus on the development and advancement of innovative cannabinoid-based nutraceutical and skincare products and brands

  • The global industrial hemp market was valued at $5.66 billion in 2020 and is expected to reach a value of $27.72 billion by 2028, growing at a CAGR of 25.17%

  • Hemp-derived cannabinoids have been studied for the last 20 years with nothing more than pre-clinical data but the new collaboration with Cinvestav and the creation of TruLife Biotech can help answer these questions and develop the products necessary for ECS deficiencies


Green Hygienics Holdings (OTCQB: GRYN), a California-based tech-driven enterprise focused on the high standard cultivation of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, recently announced that to advance R&D efforts, it has entered into a scientific research collaboration agreement with Cinvestav, the Center for Research and Advanced Studies of the National Polytechnic Institute of Mexico (Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional) (https://ibn.fm/8UnHo).

Cinvestav is a high-ranked, leading Mexican multidisciplinary scientific research institute that will work with Green Hygienics in R&D efforts to develop cannabinoid-based products targeting the endocannabinoid system (“ECS”) deficiencies in animals and humans. Cinvestav ranks fourth among Latin American research centers and 118th worldwide.

Green Hygienics is also launching TruLife Biotech, LLC. to advance studies in hemp-derived cannabinoid therapies, like the research conducted with Cinvestav. The focus of TruLife Biotech will be the development and advancement of innovative cannabinoid-based nutraceuticals, skincare products, and wellness brands addressing the ECS deficiencies in humans (https://ibn.fm/rCXOQ).

“This research collaboration will be our first project under TruLife Biotech LLC, a Green Hygienics Company focused on the development and advancement of innovative cannabinoid-based nutraceutical and skincare products and brands,” Chief Scientific Officer Dr. Levan Darjania said. “The collaboration with Cinvestav will augment ongoing efforts by both parties to identify and explore selected cannabinoids and terpenes in planned combinations that may act synergistically to protect against pain development and determine their potential efficacy as pain relievers against inflammatory and neuropathic pain.”

It is the collaborative model that Green Hygienics and Cinvestav will develop that will be used to create proprietary and effective products. “Discovery and development of cannabinoid-based products that are truly effective in producing the desired result are global tasks that are based on multidisciplinary approaches, collaborations, and partnerships. After meeting with leading researchers at Cinvestav’s Mexico City Campus, we are confident in our collaboration on the development of new and efficacious products,” COO Kyle MacKinnon added.

Even though the interaction of hemp-derived cannabinoids and the body’s ECS has been studied for the last 20 years, there is only pre-clinical data available. Still, the question that arises is how much of that data is genuine and useful. The company intends to use the new collaboration and TruLife Biotech formation to help answer these questions and develop the products necessary for ECS deficiencies, according to Dr. Darjania.

To further support the initiative, Green Hygienics has published a White Paper through Nutritional Outlook, an MJH Life Sciences(TM) brand that provides intelligent, well-informed insights and industry updates critical to the manufacturers of dietary supplements, health foods, and nutritional beverages.

The White Paper examines the therapeutic potential for cannabinoid health- and wellness-based products, but underlines the need to develop defined, consistent, and targeted products with established standards. The ultimate goal is to develop and promote scientific evidence-based ECS-modulating cannabinoid products that will be trusted by medical communities, physicians, holistic health practitioners, and wellness-oriented end users (https://ibn.fm/9929I).

According to Dr. Darjania, Green Hygienics remains committed to changing the landscape of the industry and continuing the advancement of its hemp-derived cannabinoid phyto-remedy platform, with TruLife serving as a hub of biotechnology innovations and ultimately securing a strategic advantage in the market by introducing novel cannabinoids and biodelivery methods. These steps will help cement Green Hygienics’ role in the global hemp market, which was valued at $5.66 billion worldwide in 2020. The market is expected to grow at a CAGR of 25.17% from 2021 to 2028, resulting in an estimated value of $27.72 billion by 2028 (https://ibn.fm/mZEGs) and multiple expansion opportunities for Green Hygienics and its portfolio.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork.


https://www.investorwire.com/news-articles/green-hygienics-holdings-inc-gryn-joins-forces-with-mexican-scientific-body-creates-new-company-to-research-endocannabinoid-deficiencies/

  • Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts

  • This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics

  • Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies


CBD Reality Check 

Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached a fever-pitch in recent years followed by the early-stage preclinical discoveries surrounding the tentative functional role of the endocannabinoid system (“ECS”). CBD received a further popular validation since U.S. FDA approved Epidiolex(R) as adjunctive therapy for pediatric patients with drug-resistant epilepsy.

During the last 5-8 years, CBD has been highly acclaimed and heavily hyped. Its medicinal qualities are perceived as limitless by some, and its non-psychoactive nature makes it “suitable” for just about anyone, as it has been claimed by many activists and business entities. The broad-ranging claims of CBD therapeutic utilities are endless, while monopolistic entrepreneurs are rushing the industry in droves, touting first-to-market achievements over quality, research-backed product offerings.

Current Status-Quo and Future Expectations 

A case can be made that the majority of CBD companies simply ignore the lack of efficacy in their products to avoid potentially undermining their commercial utility, preferring to exploit the “natural” label without any R&D efforts, the very efforts that could establish important evidence-based credibility for their products. Companies marketing products containing CBD have been over-exuberant in their claims about its effectiveness. They have been guilty of illegal, sleight-of-hand, exploiting public enthusiasm over cannabis/hemp by portraying all cannabinoids as not only safe but capable of ameliorating the symptoms of many serious medical conditions.

Consequently, the reputation of CBD as a universal “cure-all” puts this still promising substance in the same class as other “natural” panaceas, where anecdotal cases and overwhelmingly biased testimonials supersede the proper efficacy evaluation of already marketed CBD finished products.

Notwithstanding, while CBD and other hemp-derived cannabinoids remain a formally unproven therapeutic option with a known mechanism of action, physicians and holistic health/wellness practitioners remain open to the possible future role of these products in the field of alternative management and prophylaxis of different health conditions such as chronic inflammation and pain. Emerging companies like Green Hygienics Holdings (OTCQB: GRYN) have an opportunity to paint a brighter future for the CBD industry and provide a research-based platform for which these physicians and holistic health/wellness practitioners can specifically select and recommend beneficial products meaningful to their intended purpose of providing patient relief.

To recommend a particular cannabinoid-based product to patients and wellness-oriented end-users, those practitioners need to adequately analyze specific information and study reports on the experimentally assessed systemic exposure, bioavailability and targeted efficacy of a particular product, instead of focusing solely on the certificate of analysis (“COA”) that verifies only the concentration of bio-active ingredients and absence of harmful contaminants.

A very brief survey gathered from the published scientific and commercial papers or conference presentations indicates that even the major players in the CBD market do not possess such study results and reports to differentiate and promote their products based on at least preclinical and/or exploratory clinical study findings.

Green Hygienics is Poised to Address the Current State of the Industry

On the other hand, this particular status-quo represents the immense opportunities for R&D-driven companies like Green Hygienics in an everchanging cannabinoid market landscape. Physicians and holistic health/wellness practitioners are looking for more advanced, evidence-based cannabinoid products with high, unparalleled, and most importantly unbiased therapeutic efficacies of achievable health-beneficial effects. Green Hygienics is an enterprise that has developed a model resting on this exact premise of bringing evidence-based cannabinoid products to market, backed with unbiased therapeutic efficacies, through research-based evidence.

The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state-of-the-art technologies, the company intends to open up a whole new world of fully characterized novel cannabinoids and targeted bio-delivery technologies never before explored.

Green Hygienics is aimed at maximizing the use of intellectual and capital resources. Therefore, the Company has decided to move forward with the establishment of a state-of-art biotechnology R&D facility to focus its resources on the rational and innovative design of formulations, development and experimental evaluation of the new generation cannabinoid-based products with superior bioavailability and specifically assessed health-wellness efficacies.

Discovery and development of highly efficacious cannabinoid-based products is a global task that is based on multidisciplinary approaches, collaborations, and partnerships. Therefore, Green Hygienics is building its collaborative platform with several academic institutions, both domestically and abroad, to utilize well-established endocannabinoid system (“ECS”) target screening models and develop customized wellness products addressing ECS deficiencies. The ultimate goal is to develop and promote highly functional, experimentally assessed and supported efficacious nutraceutical products that will be trusted by medical communities, physicians, holistic health practitioners, and wellness-oriented end users.

For a more in-depth exploration on this topic, please refer to this paper published in Nutritional Outlook by Levan Darjania, PhD. (https://cnw.fm/svoTE).

About Green Hygienics Holdings

Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

The company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, Green Hygienics intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

GRYN is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives.

View GRYN’s corporate video and follow the company on Facebook, Twitter and Linkedin.

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll-Free 1.855.802.0299

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN 

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

https://www.hempwire.com/current-deficiencies-in-the-rational-development-of-cbd-based-wellness-products/

  • While more research is needed, a recent study provides some evidence that using CBD to transition from tobacco addiction holds significant promise

  • Supply chain issues are the main barrier to entry to the CBD cigarette industry for big tobacco

  • GRYN already owns the largest single industrial hemp for CBD farm in North America


Big tobacco companies are already making strategic moves into the fast-growing hemp industry, as they are exploring hemp-based alternatives to tobacco. To make this move, they require a very large supply of quality industrial hemp from which they can derive the targeted CBD products, more specifically quality hemp biomass and flower to make CBD cigarettes.

There is an emerging trend to replace smoking tobacco with smoking hemp flower. The goal is to ease the conversion from tobacco, with its addictive and negative health effects, to CBD cigarettes as a transition cigarette. While there is yet limited research providing enough evidence that CBD can sufficiently ease tobacco addiction, the results of one recent study provide anecdotal evidence that CBD may positively affect addiction. The study included 700 participants who were asked to inhale/consume CBD when they felt the urge to smoke. 42% of the participants were able to abstain from smoking cigarettes after one month of consuming CBD. This particular study was not conducted in a controlled environment and relied solely on the data provided by the participants (https://cnw.fm/dk3Mq).

Another concern for big tobacco companies interested in the hemp space is the quality of soil, as soil contamination, caused by poor farming practices in the past, is considered an issue, primarily in Europe and the Eastern parts of the United States.

Green Hygienics Holdings (OTCQB: GRYN) addresses this problem as well. The soils on its’ 824-acre Sol Valley Ranch are pristine, which is a critical factor in supply chain requirements.

With the capability of ensuring a steady supply of quality hemp, GRYN is one of the few companies that has the ability to supply big tobacco and is set to leverage multiple growth opportunities resulting from a growing demand for hemp in North America following the entry of big tobacco companies into the market.

Additionally, Green Hygienics’ U.S. Food and Drug Administration registration as of August 26, 2020, also opens up more expansive growth opportunities for the company, allowing it to supply hemp to various industries, including tobacco.

Green Hygienics is uniquely positioned to meet the growing demand for hemp resulting from big tobacco entering the market. There are only a handful of companies in the entire industry that have the capacity to meet this kind of demand.

CEO Ron Loudoun discussed the company’s growth plans in more detail when he was featured on the Bell2Bell podcast at the end of March (https://cnw.fm/77EGl).

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

https://www.cannabisnewswire.com/green-hygienics-holdings-inc-gryn-expanding-potential-for-big-tobacco-to-enter-cbd-cigarette-market/

  • “Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes industry expert

  • GRYN farm and facilities have already gained USDA Organic certification, FDA registration

  • Green Hygienics ideally positioned to innovate, drive new commercial products entirely compliant to USDA and FDA regulatory requirements


As government entities more closely analyze cannabis and the federal regulations that surround the industry, savvy companies such as Green Hygienics (OTCQB: GRYN) are already working to position themselves to offer safe, high-quality products and services. Anticipating what future regulations might look like — and working to meet those guidelines right now — is a hallmark of GRYN.

“Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes Kathleen May, a regulatory professional with more than two decades of experience in the Good Manufacturing Practice space, in a recent “Cannabis Industry Journal” article (https://ibn.fm/NiJCp). “Those that embrace the momentum and properly plan to mitigate product and business risk — those who demonstrate integrity and are truly in this space to ensure safe, effective and quality products to consumers will come out on top, gain credibility and secure brand recognition.”

Strategic planning and a long-running commitment to quality are hallmarks of Green Hygienics. The company has a track record of working to obtain significant government approvals and certifications. In April 2020, Green Hygienics received USDA Organic Certification for its 824-acre farm, which includes 400,000 square feet of greenhouse space (https://ibn.fm/ac2Cw).

The USDA Organic seal is one of the most recognized certifications among U.S. consumers and provides assurance to consumers who may be concerned about the safety of CBD products. In addition to assuring that no synthetic fertilizers, pesticides or herbicides have been used in the cultivation of hemp, the USDA organic certification ensures that farmers are using tillage and cultivation practices that maintain or improve the condition of soil and minimize soil erosion through crop rotations, cover crops and the application of plant and animal materials.

“GRYN owns the largest single, USDA Organic-Certified Industrial Hemp for CBD farms in North America,” said GRYN CEO Ron Loudoun. “Having the capacity to provide a secure supply chain of considerable size is a very significant and a clear strategic advantage. . . . This is a great milestone to have achieved. The demand for organic product is growing rapidly with increasing consumer concerns around product efficacy. USDA Organic Certification is the foundation in our objective to supply the underserved medical and pharmaceutical industry.”

In October 2020, Green Hygienics announced that it was registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 (https://ibn.fm/pQEHH).

“The achievement of FDA registration strengthens our company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike,” said GRYN chief scientific officer Dr. Levan Darjania. “The company is well positioned to instill consumer confidence and change the landscape of the industry by bringing safe and consistent products to market. With our previously announced USDA Organic Certification and FDA Facility Registration, we are well positioned to continue to innovate through the research our teams are involved in and drive new commercial products entirely compliant to USDA and FDA regulatory requirements.”

Clearly Green Hygienics is positioned to come out on top. The California-based, innovative, technology-driven enterprise is focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state-of-the-art technologies, GRYN intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, thus solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork


https://www.investorwire.com/news-articles/green-hygienics-holdings-inc-gryn-embracing-momentum-set-to-come-out-on-top/

  • Company owns largest single USDA-certified, organic hemp for CBD farm in North America with 824 acres, 400,000 square feet of greenhouse space

  • GRYN registered with U.S. Food and Drug Administration in August last year

  • Company has capacity to deliver large volume supply chain of premium quality product while remaining compliant for research or regulatory approvals


With a goal of being the leader in both compliance and capabilities in the hemp and cannabinoid supply market, California-based, innovative, technology-driven company Green Hygienics (OTCQB: GRYN) is committed to offering the highest-quality and safest products available. GRYN owns and operates the largest single USDA-certified, organic-hemp farm in North America. The farm property has 824 acres of outdoor cultivation potential and 400,000 square feet of greenhouse space, which supports the Company in this capacity.

In order to participate in long-term clinical research studies, companies must source their materials from the same company over the entire period of the study. This is critically important as it adds credibility and validity to the study results because it maintains consistency and eliminates variables.

When entering into a cooperative research study, it is essential that the Institutional Review Board (“IRB”) take into account the facilities and capabilities of the source (https://cnw.fm/hETZz). Throughout the entire study, suppliers are expected to show that they can consistently manufacture a quality product and submit sufficient information to ensure the identity, quality, purity, and potency or strength of the investigational drug.

A supply needs to be obtained from a business that has adequate facilities and capabilities, with every variable accounted for and controlled from beginning to end. The supplier must remain in compliance throughout the study while also being capable of meeting demand.

In April of last year, GRYN received its USDA Organic Certification (https://cnw.fm/NDbmg). In August, GRYN registered with the U.S. Food and Drug Administration (https://cnw.fm/2s3Mf). These strategic moves strengthened the Company’s ability to provide product efficacy to both the pharmaceutical and consumer industries. With foundational accreditations in place, and additional industry first certifications on the horizon, the Company offers research solutions that few others in the industry are capable of. Additionally, Green Hygienics offers a secure, single-origin supply chain of significant size with 400,000 square feet of indoor greenhouse space providing for year-round cultivation.

As other hemp farmers took a step back in 2020, licensed acres dropped by 27% (https://cnw.fm/DlXEv). GRYN, however, will increase its cultivation capacity in 2021 and stay committed to its mission to become the critical supply chain solution from seed to product.

The Company’s commitment and ability to provide both volume and consistency of hemp-derived cannabinoids makes it an ideal supplier for long-term studies within the medical, nutraceutical and pharmaceutical industries.

For more information about this company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

https://www.cannabisnewswire.com/green-hygienics-holdings-inc-gryn-offers-ideal-source-for-long-term-clinical-research-studies/

  • Report notes that farmers devoted fewer acreage to cultivating hemp last year

  • Hemp sales projected to balloon from $1.9 billion in 2020 to $6.9 billion in 2025, a threefold increase over five years

  • GRYN hemp farm is an 824-acre, USDA-certified organic farm including an additional 400,000 square feet of indoor greenhouse space


Despite significant growth in the CBD and hemp industry last year, licensed hemp acreage decreased in 2020 for the first time since the 2014 U.S. Farm Bill (https://ibn.fm/rMMOe). As the owner and operator of the largest single USDA-certified organic hemp farm in North America, Green Hygienics Holdings (OTCQB: GRYN) is looking to leverage its position as a prime provider of quality hemp as demand is projected to continue to increase.

“For all the growth that the hemp and CBD industry has seen as a nascent industry in recent years, last year farmers took a step back and devoted fewer resources to the crop – the enthusiasm of previous years tempered by oversupply, supply-chain issues and a lack of infrastructure,” stated a recent “Hemp Industry Daily” article. “Licensed hemp acreage decreased in 2020 for the first time since the 2014 U.S. Farm Bill established a national hemp pilot program. Licensed acres dropped to about 375,000 acres — down 27% from an estimated 511,000 acres in 2019. And less than a third of those acres were planted in 2020.”

According to Nielsen Global Connect, a division of Nielsen that focuses on data for manufacturers and retailers, “hemp’s 2020 sales of $1.9 billion will balloon to $6.9 billion in 2025, a threefold increase over five years.”

Called a “sleeping giant,” Green Hygienics owns an 824-acre, USDA-certified organic hemp farm including an additional 400,000 square feet of greenhouse space. GRYN’s farm represents a critical supply chain solution in a space where dwindling acres make property and cultivation an invaluable commodity.

Facing a growing market, the ability to provide volume and consistency will become an essential piece of a successful venture. Green Hygienics maintains these attributes and can produce safe and consistent product on a large scale — outdoors in the field and hemp year-round indoors in the greenhouses — making it an attractive candidate, both as a supplier and as an investment, for savvy investors eyeing the growing potential the market provides.

Green Hygienics is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partnering with CPG (consumer-packaged-goods) and pharmaceutical companies.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork

ARTICLE LINK:  https://www.cannabisnewswire.com/green-hygienics-holdings-gryn-leverages-fda-registration-usda-ccof-certification-as-powerful-competitive-differentiator/








  • Green Hygienics poised to become most highly certified hemp company in industry to differentiate itself from competition

  • Anticipating tightening of regulatory standards, GRYN already achieved FDA registration and USDA/CCOF certification proving highest standards of product quality, transparency and safety

  • With certifications to prove high-quality products, Green Hygienics appears ideally positioned to offer growth potential in increasingly quality-aware market


As an innovative technology-driven enterprise, Green Hygienics Holdings (OTCQB: GRYN) is dedicated to delivering the highest operating standards of industrial hemp cultivation and processing, and manufacturing of pharmaceutical-grade bioactive cannabinoids. Poised to bring safe and consistent products to market and thus change the industry’s landscape and enhance consumer confidence, GRYN is committed to becoming the most highly certified hemp company in the industry (https://cnw.fm/nOulJ).

Last year was a year of success for Green Hygienics as the company achieved important milestones that lie at the heart of its value proposition. The first is registration with the U.S. Food and Drug Administration, which enhances GRYN’s core mission to provide processing and product safety, transparency and reliability both to consumers and the pharmaceutical industry.

The second is the USDA Organic Certification (7 CFR Part 205) issued by the California Certified Organic Farmers, which allows Green Hygienics to cultivate and process post-harvest industrial hemp and supply certified organic hemp products to national and international markets from its Sol Valley Ranch property. With its 824-acre hemp farm, including 400,000 square feet of indoor greenhouse space, GRYN has become the largest single USDA-certified organic hemp farm in North America (https://www.cnw.fm/mVeaG).

Green Hygienics appears ideally positioned to remain on the research-based innovation path and drive new product commercialization fully complaint to USDA and FDA regulatory requirements. The company intends to rationally design and deliver novel fit-for-purpose cannabinoids and targeted bio-delivery technologies, using cutting-edge technology to solve the issues of product stability, pharmacokinetics, biological tissue distribution and systemic bioavailability to improve the lives of billions.

With an emerging push in the market as consumers ask for safe and efficacious products while industries such as medical, nutraceutical and pharmaceutical are seeking a secure supply chain, product quality and product associated evidence-based functionality become strong differentiators among medical practitioners and customers. The company that can address these unmet market needs could be well-placed to secure a strategic advantage in the marketplace and Green Hygienics looks poised to achieve precisely that and to become a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace.

As GRYN intends to become the most highly certified hemp company in the industry, it presents investors with an opportunity to invest in a company that uniquely positions itself as a trusted source that delivers safe and premium quality products to consumers and to CPG (consumer-packaged-goods) and pharmaceutical companies. With certifications to prove the highest operating standards, Green Hygienics seems well-positioned to offer growth potential in a market that is becoming increasingly quality-aware.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.



 
ARTICLE LINK:
https://www.investorwire.com/news-articles/green-hygienics-holdings-inc-gryn-announces-partnership-with-leading-hemp-law-firm/


  • GRYN positioning itself for rapid growth in 2021

  • Retaining expert counsel with innate understanding of cannabis law is necessary step as company builds highly differentiated business model

  • Green Hygienics’ growth strategy includes rollout of omnichannel bricks-and-clicks program featuring multiple premium brands


As Green Hygienics Holdings (OTCQB: GRYN) wraps up its first successful crop harvest and enters the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. GRYN, an innovative technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, made the decision in anticipation of rapid growth in 2021.

“When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said Green Hygienics CEO Ron Loudoun. “Navigating regulatory compliance in an emerging industry is no small task, but a very important one to our company, and retaining counsel of such an established law firm with an innate understanding of cannabis law is a necessary step as we build out our highly differentiated business model.”

In addition to retaining McAllister Garfield, part of Green Hygienics’ strategy for growth includes the rollout of an omnichannel bricks-and-clicks program featuring multiple premium brands layering over different market segments in the hemp industry. GRYN’s partnership with McAllister Garfield will provide insight and expertise in navigating regulatory compliance issues.

The firm will also provide invaluable advice and support throughout the rollout, including assistance with retail opportunities. Specifically, GRYN is working with McAllister Garfield to obtain three business licenses in the downtown vicinity of San Diego for the following:

  • a hemp-centric coffee house

  • a smoking lounge

  • An all-things-hemp dispensary and storefront


“We are pleased to be working with Green Hygienics Holdings, Inc., a promising company which puts a focus on compliance and consumer safety,” said McAllister Garfield’s hemp/CBD chairman David Wunderlich. “McAllister Garfield provides sophisticated business advice lending guidance on foundational documents, mergers and acquisitions, transactional and employment law, litigation, and administrative regulatory enforcement. Our team of lawyers has been present in the hemp industry from the very beginnings and offers a suite of solutions helping our clients through to positive outcomes as they run the regulatory gauntlet.”

Green Hygienics is committed to consistently delivering safe, premium-quality products to consumers; the company is also looking to partner with CPG (consumer-packaged-goods) and pharmaceutical companies in its mission to offer hemp-based products that consumers are searching for. GRYN is focused on becoming a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace.

In addition, GRYN is exploring the full range of novel cannabinoids and targeted bio-delivery technologies with the objective of solving issues of stability, pharmacokinetics, biological tissue penetration and bioavailability. The company has assembled a team of visionary agrotechnology, pharmaceutical, and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with the mission to improve lives.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork.




ARTICLE LINK: https://www.tip.us/tips/gryn.php


Green Hygienics Holdings Inc. (OTCQB: GRYN)


Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state of the art technologies, the company intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

Dedicated to creating the hemp industry's safest and finest quality products, the company will be uniquely positioned to deliver product efficacy and supply chain solutions to consumers, as well as to leverage these within its own products and brand portfolio.

USDA Organic Certification and FDA Registration

On August 26, 2020, Green Hygienics registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002. This registration strengthens the company's core mission to provide product efficacy to the pharmaceutical industry and consumers alike.

On September 30, 2020, Green Hygienics was granted USDA Organic Certification (7 CFR Part 205) for the cultivation and post-harvest processing of industrial hemp by the California Certified Organic Farmers for its Sol Valley Ranch property. This certification further enables the company to supply certified organic hemp products to national and international markets.

Market Opportunity

Green Hygienics is focused on finding, acquiring and developing strategically positioned businesses, as well as the best innovations within the hemp industry – a fast-progressing market with remarkable opportunities for growth. The industrial hemp market is expected to reach $5.33 billion in 2020 and is projected to rise to $15.26 billion by 2027, achieving a CAGR of 15.8%, per Grand View Research.

Capital Structure

GRYN has less than 42 million shares outstanding, fully diluted. The company has just 7.2 million common shares in float and boasts a balance sheet with no toxic debt or overhang.

Key Management

Dr. Levan Darjania serves as the company's Chief Science Officer. Darjania has over 26 years of experience in biotechnology and pharmaceutical drug development. His research and development experience has led him to develop many in-house and collaborative R&D programs over the course of his career.

Kyle MacKinnon serves as GRYN's Chief Operating Officer. He has extensive knowledge in cannabis processing and was previously the Business Development Manager of Advanced Extraction Systems Inc., a leader in CO2 Supercritical Fluid Extraction. MacKinnon brings over 20 years of sales and management experience to the company.

Ronald Loudoun is the President, CEO, Secretary and Director of Green Hygienics. He received an undergraduate business degree from the British Columbia Institute of Technology. Before joining Green Hygienics, he was the founder and a director of renewable energy firm Archer CleanTech Inc.

Jerry Halamuda is the Senior Vice President of Business Development of the company's Agriculture Division. He has an extensive career working in the agriculture and horticulture industry. Halamuda has founded, managed and operated multiple successful companies, including Color Spot Nurseries.

John Gildea is GRYN's Senior Vice President of Corporate Development. He has over 20 years of experience working within the private and public markets. His expertise includes negotiating and structuring private and public financing and mergers. During the course of his work, Gildea has established trusted relationships with a network of equity and capital partners.